Ionis Pharma (IONS) Misses Q4 EPS Views

Ionis Pharma (NASDAQ: IONS) reported Q4 EPS of ($0.59), $0.11 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $51.6 million versus the consensus estimate of $49.32 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Piper Sandler defends Oracle ahead of earnings, sees $2.2 billion OCI upside
• Ionis completes enrollment in Phase 3 Angelman syndrome study